HIFing the Brakes: Therapeutic Opportunities for Treatment of Human Malignancies

Sci. STKE, 30 May 2006
Vol. 2006, Issue 337, p. pe25
DOI: 10.1126/stke.3372006pe25

HIFing the Brakes: Therapeutic Opportunities for Treatment of Human Malignancies

  1. Joseph A. Garcia*
  1. Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390–8573, USA.
  1. *Contact information. E-mail, joseph.garcia{at}utsouthwestern.edu


The unfortunate ability of tumor cells to survive and expand in an uncontrolled manner has captivated the attention of clinicians and basic scientists alike. The molecular mechanisms that tumor cells use to grow are the very same pathways used in normal cell growth and differentiation. One important pathway conferring a growth advantage on tumor cells is the epidermal growth factor receptor (EGFR) pathway. Signaling through the EGFR leads to activation of the phosphatidylinositol 3-kinase and Akt pathway and to increased activity of multiple effectors, including hypoxia-inducible factors (HIFs), which are cellular transcription factors involved in environmental stress response. The target genes that HIF members stimulate that are relevant to tumor growth include transcriptional activators and repressors and cytokines and growth factors, as well as their receptors. In this Perspective, findings from several recent studies are discussed in terms of their effect on the signal transducers, target genes, and tumor properties that are ultimately affected during EGFR-stimulated HIF signaling in cancer cells.


J. A. Garcia, HIFing the Brakes: Therapeutic Opportunities for Treatment of Human Malignancies. Sci. STKE 2006, pe25 (2006).

Proteomics Identification of Annexin A2 as a Key Mediator in the Metastasis and Proangiogenesis of Endometrial Cells in Human Adenomyosis
S. Zhou, T. Yi, R. Liu, C. Bian, X. Qi, X. He, K. Wang, J. Li, X. Zhao, C. Huang et al.
MCP 11, M112.017988-M112.017988 (1 July 2012)

Adenomatous Polyposis Coli and Hypoxia-inducible Factor-1{alpha} Have an Antagonistic Connection
I. P. Newton, N. S. Kenneth, P. L. Appleton, I. Nathke, and S. Rocha
Mol. Biol. Cell 21, 3630-3638 (1 November 2010)

Mechanism of Hypoxia-Induced NF-{kappa}B
C. Culver, A. Sundqvist, S. Mudie, A. Melvin, D. Xirodimas, and S. Rocha
Mol. Cell. Biol. 30, 4901-4921 (15 October 2010)

Science Signaling Podcast: 13 January 2009
J. D. Scott, W. Wong, and A. M. VanHook
Sci Signal 2, pc1-pc1 (13 January 2009)

Digoxin and other cardiac glycosides inhibit HIF-1{alpha} synthesis and block tumor growth
H. Zhang, D. Z. Qian, Y. S. Tan, K. Lee, P. Gao, Y. R. Ren, S. Rey, H. Hammers, D. Chang, R. Pili et al.
Proc. Natl. Acad. Sci. USA 105, 19579-19586 (16 December 2008)

Regulation of gene expression by hypoxia
N. S. Kenneth, and S. Rocha
Biochem. J. 414, 19-29 (15 August 2008)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882